Nippon India Nifty Pharma ETF
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Nifty Pharma ETF
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Exchange Traded Funds (ETFs)
Launch Date
: 21-Jun-2021
Fund Manager
: Jitendra Tolani
Net Assets (Rs. cr)
: 1247.9
Nippon India Nifty Pharma ETF - Nav Details
Nav Date
: 13-Apr-2026
NAV [Rs.]
: 22.6717
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: Nil
Nippon India Nifty Pharma ETF- NAV Chart
Nippon India Nifty Pharma ETF- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 1.2 | -3.22 | -1.88 | -0.33 | 8.53 | 21.52 | - | 9.96 |
| Category Avg | 4.35 | 2.83 | -5.44 | -0.56 | 21.42 | 17.37 | 13.31 | 11.68 |
| Category Best | 10.19 | 11.46 | 16.8 | 54.86 | 151.42 | 44.66 | 36.21 | 157.41 |
| Category Worst | 0.03 | -10.91 | -90.95 | -86.27 | -13.57 | 2.3 | 4.26 | -23.33 |
Nippon India Nifty Pharma ETF- Latest Dividends
No Records Found
Nippon India Nifty Pharma ETF- Investment Details
Min. Investment(Rs.)
: 1000
Increm.Investment(Rs.)
: 0
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 22.91 | 1627004 | 285.89 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 9.41 | 936071 | 117.46 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 9.32 | 195504 | 116.26 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 8.49 | 864998 | 105.89 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 6.91 | 372631 | 86.22 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 5.43 | 160696 | 67.81 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 4.76 | 597928 | 59.35 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 4.49 | 429667 | 56.04 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 3.96 | 231647 | 49.38 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 3.80 | 89603 | 47.48 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 3.17 | 1096408 | 39.56 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.80 | 174028 | 34.90 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.74 | 213172 | 34.13 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.69 | 385657 | 33.59 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 2.09 | 126509 | 26.11 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 1.67 | 122524 | 20.78 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 1.64 | 7909 | 20.49 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 1.46 | 64856 | 18.19 |
| Equity | Wockhardt | Pharmaceuticals & Biotechnology | 1.19 | 126552 | 14.87 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 1.04 | 951708 | 12.99 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
7,40,030.99
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Jitendra Tolani
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
